Author: Lee, Pureum; Kim, Chang-Ung; Seo, Sang Hawn; Kim, Doo-Jin
Title: Current Status of COVID-19 Vaccine Development: Focusing on Antigen Design and Clinical Trials on Later Stages Cord-id: ssekm6ok Document date: 2021_2_26
ID: ssekm6ok
Snippet: The global outbreak of coronavirus disease 2019 (COVID-19) is still threatening human health, economy, and social life worldwide. As a counteraction for this devastating disease, a number of vaccines are being developed with unprecedented speed combined with new technologies. As COVID-19 vaccines are being developed in the absence of a licensed human coronavirus vaccine, there remain further questions regarding the long-term efficacy and safety of the vaccines, as well as immunological mechanism
Document: The global outbreak of coronavirus disease 2019 (COVID-19) is still threatening human health, economy, and social life worldwide. As a counteraction for this devastating disease, a number of vaccines are being developed with unprecedented speed combined with new technologies. As COVID-19 vaccines are being developed in the absence of a licensed human coronavirus vaccine, there remain further questions regarding the long-term efficacy and safety of the vaccines, as well as immunological mechanisms in depth. This review article discusses the current status of COVID-19 vaccine development, mainly focusing on antigen design, clinical trials in later stages, and immunological considerations for further study.
Search related documents:
Co phrase search for related documents- ab function and ab response: 1
- ab response and ad adenovirus: 1
Co phrase search for related documents, hyperlinks ordered by date